David Hallal

KLRS

David Hallal serves as director, officer: Chief Executive Officer at Kalaris Therapeutics Inc (KLRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$12.90M

Net Position

Net Seller

$12.90M

Companies Traded

SRRK, KLRS

Active Period

Jan 2022 – Apr 2026

9 total trades

Most Recent

Sell SRRK

Apr 20, 2026 · $1.52M

David Hallal's Insider Trading at Kalaris Therapeutics Inc (KLRS)

Buys

0 · $0.00

Sells

7 · $8.93M

Total Shares Bought

Total Shares Sold

1,157,004

KLRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 21, 2022	Sell	600,000	$8.45	$5.07M	138,153
Sep 30, 2022	Sell	400,000	$7.35	$2.94M	720,965
Jul 21, 2022	Sell	4,227	$5.33	$22.5K	2,073,662
Jun 6, 2022	Sell	65,725	$3.67	$241.1K	2,077,889
Apr 22, 2022	Sell	4,227	$5.87	$24.8K	2,143,614
Mar 11, 2022	Sell	65,725	$7.48	$491.9K	2,173,085
Jan 25, 2022	Sell	17,100	$8.01	$136.9K	2,213,566